Intrinsic Value of S&P & Nasdaq Contact Us

Elutia Inc. ELUT NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
71/100
3/7 Pass
SharesGrow Intrinsic Value
$28.86
+2366.7%
Analyst Price Target
$8.88
+659%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Elutia Inc. (ELUT) trades at a trailing P/E of 0.9. Trailing earnings yield is 111.56%. Graham Number is $4.27.

Criteria proven by this page:

  • VALUE (100/100, Pass) — P/E is below market average (0.9); analyst target implies upside (+659%); earnings yield beats bond yields (111.56%).
  • Trailing Earnings Yield 111.56% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.
  • Analyst consensus target $8.88 (+659% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 71/100 with 3/7 criteria passed.

SharesGrow 7-Criteria Score
71/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
FUTURE
100/100
Analyst consensus
→ Forecast
PAST
25/100
→ Income
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
50/100
→ Income
~
GROWTH
58/100
→ Income
INCOME
100/100
→ Income

Valuation Snapshot — ELUT

Valuation Multiples
P/E (TTM)0.9
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio1.73
P/S Ratio2.54
EV/EBITDA-1.7
Per Share Data
EPS (TTM)$1.25
Book Value / Share$0.65
Revenue / Share$0.44
FCF / Share$-0.03
Yields & Fair Value
Earnings Yield111.56%
Dividend Yield0.00%
Graham Number$4.27
SharesGrow IV$28.86 (+2366.7%)
Analyst Target$8.88 (+659%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2018 -13.4 0.00 -3.56 3.96 -
2019 -13.0 -3.50 -2.81 3.61 -
2020 -6.4 -0.07 6.69 3.27 -
2021 -2.6 -0.23 4.87 1.39 -
2022 -1.8 0.00 -11.68 2.47 -
2023 -1.0 0.08 -1.02 1.59 -
2024 -2.0 0.20 -2.35 4.46 -
2025 0.5 0.00 1.04 2.33 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2018 $-1.08 $39.04M $-11.57M -29.6%
2019 $-1.12 $42.9M $-11.94M -27.8%
2020 $-2.13 $42.68M $-21.83M -51.1%
2021 $-2.38 $47.39M $-24.83M -52.4%
2022 $-2.38 $23.85M $-32.9M -137.9%
2023 $-2.07 $24.75M $-37.66M -152.2%
2024 $-1.86 $24.38M $-53.95M -221.3%
2025 $-0.79 $12.29M $53.38M 434.2%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $-0.54 $-0.54 – $-0.54 $12M $12M – $12M 1
2027 $-0.51 $-0.51 – $-0.51 $13.3M $13.3M – $13.3M 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message